Hosted on MSN
Hims & Hers enters direct-to-consumer lab testing
Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest Diagnostics. Customers will have access to more than 120 biomarker tests across ...
Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base EL MONTE, Calif., December 22, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: ...
Woman's World on MSN
Medicare Lab Test Costs Changing Soon-What Seniors Need To Know Now
At the end of January, Medicare users are going to face a major shakeup. Starting February 1, Americans on the government-funded health insurance program are expected to feel the effects of reduced ...
The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ...
Hosted on MSN
Q3 earnings highlights: Quest (NYSE:DGX) vs the rest of the testing & diagnostics services stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q3, starting ...
In September 2015, Dr. Dena Marrinucci set out to perfect a tabletop device that could rapidly test a small amount of blood, returning results for more than 30 routine tests in under 30 minutes. If ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results